Delisting riskPopularity #4,921
Elutia (ELUT)
Develops drug-eluting biomatrices for surgical reconstruction and implanted-device complications.
$0.8102
After-hours close0.00 (0.00%)
At close$0.8102(−5.06%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Insiders | 21.62% | 9.58M shares | |
|---|---|---|---|
| 8 holders · as of Sep 14, 2026 | |||
| Strategic holders | 21.50% | 9.52M shares | |
| 1 holder · as of Mar 13, 2025 | |||
| Other | 56.88% | 25.19M shares | |
| remainder | |||
44.29M company shares as of Sep 23, 2026 · holders as of their latest filing
13F
No 13F holders on record.
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Kevin Rakinincl. HighCape Partners GP II, L.P., HighCape Partners, L.P. +7 more | 13.00% | 5.24M | 13D | Dec 15, 2025 |
| Nantahala Capital Management, LLC | 9.99% | 4.12M | 13G | Feb 13, 2026 |
| Orin Hirschman | 7.60% | 3.07M | 13G | Jan 28, 2026 |
| Knollwood Investment Advisory, LLC | 6.30% | 2.56M | 13G | Feb 13, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jan 30, 2026 | Guido J. Neelsdirector | Purchase | 20,000 | $1.04 | 118,750 |
| Jan 30, 2026 | Kevin Rakindirector, 10 percent owner: | Purchase | 70,000 | $1.06 | 196,120 |
| Jan 28, 2026 | Guido J. Neelsdirector | Purchase | 15,000 | $1.06 | 83,750 |
| Jan 29, 2026 | Guido J. Neelsdirector | Purchase | 15,000 | $1.06 | 98,750 |
| Dec 17, 2025 | Kevin Rakindirector, 10 percent owner: | Purchase | 50,000 | $0.5199 | 322,419 |
| Dec 17, 2025 | Matthew Fergusonofficer: CHIEF FINANCIAL OFFICER | Purchase | 60,000 | $0.5300 | 447,110 |
| Dec 17, 2025 | C. Randal Millsdirector, officer: PRESIDENT AND CEO | Purchase | 3,000 | $0.5100 | 379,204 |
| Dec 17, 2025 | Brigid Makesdirector | Purchase | 25,000 | $0.5200 | 27,000 |
| Dec 17, 2025 | David Colpmandirector | Purchase | 12,500 | $0.5100 | 31,098 |
| Dec 1, 2025 | Matthew Fergusonofficer: CHIEF FINANCIAL OFFICER | Purchase | 4,500 | $0.6500 | 373,571 |
House and Senate disclosures
Not reported.
